Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Top Cited Papers
- 1 April 2001
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 19 (1) , 225-252
- https://doi.org/10.1146/annurev.immunol.19.1.225
Abstract
Recent advances in the understanding of T cell activation have led to new therapeutic approaches in the treatment of immunological disorders. One attractive target of intervention has been the blockade of T cell costimulatory pathways, which result in more selective effects on only those T cells that have encountered specific antigen. In fact, in some instances, costimulatory pathway antagonists can induce antigen-specific tolerance that prevents the progression of autoimmune diseases and organ graft rejection. In this review, we summarize the current understanding of these complex costimulatory pathways including the individual roles of the CD28, CTLA-4, B7-1 (CD80), and B7-2 (CD86) molecules. We present evidence that suggests that multiple mechanisms contribute to CD28/B7-mediated T cell costimulation in disease settings that include expansion of activated pathogenic T cells, differentiation of Th1/Th2 cells, and the migration of T cells into target tissues. Additionally, the negative regulatory role of CTLA-4 in autoimmune diseases and graft rejection supports a dynamic but complex process of immune regulation that is prominent in the control of self-reactivity. This is most apparent in regulation of the CD4(+)CD25(+)CTLA-4(+) immunoregulatory T cells that control multiple autoimmune diseases. The implications of these complexities and the potential for use of these therapies in clinical immune intervention are discussed.Keywords
This publication has 165 references indexed in Scilit:
- PREVENTION OF RENAL ALLOGRAFT REJECTION IN PRIMATES BY BLOCKING THE B7/CD28 PATHWAY1Transplantation, 1999
- High Concentrations of Antigenic Ligand Activate and Do Not Tolerize Naive CD4 T Cells in the Absence of CD28/B7 CostimulationCellular Immunology, 1997
- The Complexities of T‐Cell Co‐stimulation: CD28 and BeyondImmunological Reviews, 1996
- T cell Clones to Epitopes of Glutamic Acid Decarboxylase 65 Raised from Normal Subjects and Patients with Insulin-dependent DiabetesJournal of Autoimmunity, 1996
- Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.Journal of Clinical Investigation, 1996
- Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouseInternational Immunology, 1995
- Stimulation of transforming growth factor‐β1 transcription by cyclosporineFEBS Letters, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- Genetic and molecular aspects of demyelinationImmunology Today, 1986